Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Aoxing Pharma begins trial of sublingual buprenorphine/naloxone for opioid addiction

Dec. 13, 2010

Alkermes presents phase II data on ALKS-33 in alcohol dependence

Dec. 10, 2010

CBLB-502 receives FDA orphan drug status for prevention of death following irradiation

Dec. 1, 2010

Enrollment completed in Nabi Biopharma' second phase III NicVAX trial

Nov. 10, 2010

Nicotine vaccine NIC-002 enters phase II study

Nov. 8, 2010

AEOL-10150 promotes survival in nonhuman primates exposed to radiation

Nov. 5, 2010

Soligenix presents preliminary phase Ib safety data on RiVax

Nov. 4, 2010

Alkermes' combination therapy for cocaine addiction to advance to phase II

Oct. 26, 2010

Omeros receives additional grant from NIDA for addiction program

Oct. 18, 2010

FDA approves Vivitrol for prevention of relapse to opioid dependence

Oct. 13, 2010